On Saturday, May 11, we are pleased to welcome Tamar Todd, Legal Counsel, New Approach, to the Horizons stage to as part of the “State initiatives to support psychedelic research and access” session. Learn more and register at buff.ly/3Egr4DU

#Horizonsnyc

Horizons: Perspectives on Psychedelics will be at the historic New York Academy of Medicine. Established in 1847, NYAM has been at the forefront of medical research, education, and advocacy for over 175 years. Join us in this venerable space: buff.ly/3Eoo2jd

On Friday, May 10, we are pleased to welcome Candace Oglesby, LCPC, Psychotherapist, Jurnee Mental Health Consulting, to the Horizons stage to as part of the “Listening to BIPOC Therapists” session. Learn more and register at buff.ly/3Egr4DU

#Horizonsnyc

We offer our thanks to Psychedelic Health Equity Initiative, a Friend Sponsor of the 16th annual Horizons: Perspectives on Psychedelic conference on May 8-11 at the New York Academy of Medicine. Join us and PHEI in May at Horizons: buff.ly/3Egr4DU.

#Horizonsnyc

On Friday, May 10, we are pleased to welcome Tehseen Noorani, PhD, Senior Research Fellow, University of Auckland, to the Horizons stage to discuss “the enigma of psychedelic trial design.” Learn more and register at buff.ly/3Egr4DU

There are just a few days left to register for Horizons New York at the current price tier. On May 1 prices will increase, followed by an additional increase on May 6 (show week). If you haven't already, register today at buff.ly/3Egr4DU

We offer our thanks to Fluence, a Friend Sponsor of the 16th annual Horizons: Perspectives on Psychedelic conference on May 8-11 at the New York Academy of Medicine. You can learn more about Fluence at fluencetraining.com. Join us at Horizons: buff.ly/3Egr4DU.

On Thursday, May 9, we are pleased to welcome Dr. Kelley O’Donnell, MD, PhD, to the Horizons stage to as part of a session about “Educating the next generation of psychedelic therapists.” Learn more and register at buff.ly/3Egr4DU

Horizons: Perspectives on Psychedelics
May 8-11
New York City

Horizons is the longest-running annual psychedelic conference in the world.

We are proud to support Horizons PBC as a Community Ally. Use our link for 15% off!

r1.events-registration.com/HorizonsNY2024…

On Friday, May 10, we are pleased to welcome Victor Alfonso Cabral, LSW, to the Horizons stage to as part of the “Listening to BIPOC Therapists” session. Learn more and register at buff.ly/3Egr4DU

We offer our thanks to Dr. Bronner’s, a Friend Sponsor of the 16th annual Horizons: Perspectives on Psychedelic conference on May 8-11 at the New York Academy of Medicine. Learn more and join us at Horizons by registering at buff.ly/3Egr4DU.

Each year on April 19 we remember Dr. Albert Hofmann’s memorable journey home from his lab in Basel, Switzerland in 1943. To celebrate, we’re offering registration discount of 10% off. Use this special link before end of day April 20 to enjoy: buff.ly/4aFKfXj

On Friday, May 10, we are pleased to welcome Natalie Gukasyan, MD, Assistant Professor, Columbia University Medical Center, to the Horizons New York stage to discuss “the enigma of psychedelic trial design.” Learn more and register at buff.ly/3Egr4DU

#Horizonsnyc

On Friday, May 10, Dr. Rachel Yehuda, Director of the Mt. Sinai Center of Psychedelic Psychotherapy and Trauma Research, presents at Horizons New York to discuss the role of psychotherapy in psychedelic-assisted treatments. Learn more and register at buff.ly/3Eoo2jd

Dr. Harriet de Wit, Professor of Psychiatry and Behavioral Neuroscience at the University of Chicago, will discuss the complexities of trial designs for studies of psychedelic drugs and treatments at Horizons New York on May 10. Learn more, and register at buff.ly/3Egr4DU

On Friday, May 10, Dr. Hokanson will unveil plans for a state-funded, open-label psilocybin trial for diverse populations in the United States during the Horizons New York conference. Learn more and register at buff.ly/3Egr4DU.

#Horizonsnyc

Paula Schnurr, PhD, Executive Director, National Center for PTSD, Department of Veterans Affairs, will be presenting “Studying MDMA-assisted therapy for PTSD within veteran populations” on Friday, May 10th, at Horizons New York 2024. Learn more: buff.ly/3Egr4DU

Benjamin Kelmendi, MD, Yale School of Medicine, will be presenting on May 10 at Horizons New York. He will share preliminary study results on “Neural correlates of the effects of psilocybin in obsessive-compulsive disorder.” Learn more and register at buff.ly/3Egr4DU

Terence Ching from the Yale School of Medicine will be sharing preliminary study results at Horizons New York in a session entitled “Neural correlates of the effects of psilocybin in obsessive-compulsive disorder (OCD)” Learn more and register at buff.ly/3Egr4DU

We’re now one month away from the start of “Horizons: Perspectives on Psychedelics,” the longest-running annual psychedelic community event in the world. The conference will take place from May 8-11, 2024 at the New York Academy of Medicine.
Learn more at buff.ly/3Egr4DU